The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models
Abstract
Epidemiological studies in humans, as well as experimental studies in animal models, have shown an association between visceral obesity and dyslipidemia, insulin resistance, and type 2 diabetes mellitus. Recently, attention has been focused on the excessive accumulation of triglycerides (TG) in the liver as part of this syndrome. In this review, important principles of the pathophysiological involvement of the liver in the metabolic syndrome obtained in rodent models are summarized. We focus on non-alcoholic causes of steatosis, because the animal experiments we refer to did not include alcohol as an experimental condition. In general, there is continuous cycling and redistribution of non-oxidized fatty acids between different organs. The amount of TG in an intrinsically normal liver is not fixed but can readily be increased by nutritional, metabolic, and endocrine interactions involving TG/free fatty acid (FFA) partitioning and TG/FFA metabolism. Several lines of evidence indicate that hepatic TG accumulation is also a causative factor involved in hepatic insulin resistance. Complex interactions between endocrine, metabolic, and transcriptional pathways are involved in TG-induced hepatic insulin resistance. Therefore, the liver participates passively and actively in the metabolic derangements of the metabolic syndrome. We speculate that similar mechanisms may also be involved in human pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic syndrome is also an independent indicator for chronic kidney disease [636] and may be related to liver steatosis [637].”
In the citing paper
“Steatosis has often been associated with hepatic IR in the context of obesity [43].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785
Coburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
Shimomura, I., Bashmakov, Y. K., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 704
Research works printed but not linked: 3
- 10.1161/atvb.21.12.2051 · DOI
- 10.1210/jcem.87.7.8638 · DOI · Paper page
- 2001, Int J Obes Relat Metab Disord, 25, S35
Cited by
Sorted by citations
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
Triglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170012 · Cited by 1,324
Fructose, insulin resistance, and metabolic dyslipidemia
Basciano, H., Federico, L. M., & Adeli, K. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-5 · Cited by 858
Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types
Buettner, R., Parhofer, K. G., Woenckhaus, M., Wrede, C. E., Kunz-Schughart, L. A., Schölmerich, J., & Bollheimer, L. C. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01909 · Cited by 704
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
(2010) · doi:10.1016/j.cmet.2010.06.009 · Cited by 512
Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver
Monetti, M., Levin, M. C., Watt, M. J., Sajan, M. P., Marmor, S., Hubbard, B. K., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.005 · Cited by 511
Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M., & Neuschwander-Tetri, B. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90272.2008 · Cited by 378
Fraulob, J. C., Ogg-Diamantino, R., Fernandes‐Santos, C., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-83 · Cited by 451
Nonalcoholic fatty liver disease and the metabolic syndrome
Marchesini, G., Marzocchi, R., Agostini, F., & Bugianesi, E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174153.53683.f2 · Cited by 421
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease
Li, Z.-Z., Berk, M. P., McIntyre, T. M., & Feldstein, A. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807616200 · Cited by 414
Effect of ethanol on lipid metabolism
You, M., & Arteel, G. E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.037 · Cited by 357
Jeon, B. T., Jeong, E. A., Shin, H. J., Lee, Y., Lee, D. H., Kim, H. J., Kang, S. S., Cho, G. J., Choi, W. S., & Roh, G. S. (2012) · Diabetes · doi:10.2337/db11-1498 · Cited by 366
Gary‐Bobo, M., Elachouri, G., Gallas, J., Janiak, P., Marini, P., Ravinet‐Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., et al. (2007) · Hepatology · doi:10.1002/hep.21641 · Cited by 309
Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members
Lake, A. C., Sun, Y., Li, J., Kim, J. E., Johnson, J., Li, D., Revett, T., Shih, H. H., Liu, W., Paulsen, J. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500290-jlr200 · Cited by 294
Roles of PPARs in NAFLD: Potential therapeutic targets
Tailleux, A., Wouters, K., & Staels, B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.016 · Cited by 289
Experimental rat models to study the metabolic syndrome
Aleixandre, A., & Miguel, M. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509990729 · Cited by 271
Non-Alcoholic Fatty Liver Disease
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_19 · Cited by 253
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Liu, Q., Bengmark, S., & Qu, S. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-42 · Cited by 233
Prevalence of Body Iron Excess in the Metabolic Syndrome
Bozzini, C., Girelli, D., Olivieri, O., Martinelli, N., Bassi, A., De Matteis, G., Tenuti, I., Lotto, V., Friso, S., Pizzolo, F., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2061 · Cited by 224
Peluso, M. R. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100802 · Cited by 218
Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia
Ooga, T., Sato, H., Nagashima, A., Sasaki, K., Tomita, M., Soga, T., & Ohashi, Y. (2011) · Molecular BioSystems · doi:10.1039/c0mb00141d · Cited by 215
Newberry, E. P., Xie, Y., Kennedy, S., Luo, J., & Davidson, N. O. (2006) · Hepatology · doi:10.1002/hep.21369 · Cited by 206
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Zufiría, M., Gil-Bea, F. J., Fernández‐Torrón, R., Poza, J. J., Muñoz-Blanco, J. L., Rojas‐García, R., Riancho, J., & de Munaín, A. L. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.004 · Cited by 204
Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease
Souza-Mello, V. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1012 · Cited by 182
Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B–null mice
Choi, Y. H., Park, S., Hockman, S. C., Zmuda‐Trzebiatowska, E., Svennelid, F., Haluzı́k, M., Gavrilova, O., Ahmad, F., Pepin, L., Napolitano, M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24867 · Cited by 187
Cytosolic Lipid Droplets Increase in Size by Microtubule-Dependent Complex Formation
Boström, P., Rutberg, M., Ericsson, J., Holmdahl, P., Andersson, L. K., Frohman, M. A., Borén, J., & Olofsson, S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000179676.41064.d4 · Cited by 183
PLD1 and ERK2 regulate cytosolic lipid droplet formation
Andersson, L. K., Boström, P., Ericson, J., Rutberg, M., Magnusson, B., Marchesan, D., Ruiz, M., Asp, L., Huang, P. C., Frohman, M. A., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.02941 · Cited by 180
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
Dixon, L. J., Berk, M. P., Thapaliya, S., Papouchado, B. G., & Feldstein, A. E. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.45 · Cited by 159
The clinical biochemistry of obesity.
Sikaris, K. A. (2004) · PubMed Central · Cited by 158
Li, J., Bosch‐Marcé, M., Nanayakkara, A., Savransky, V., Fried, S. K., Semenza, G. L., & Polotsky, V. Y. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00293.2005 · Cited by 168
Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin
González, A. S., Bellido, D., Soto, M. B., Pértega-Díaz, S., Olmos, M. Á. M., & Vidal, O. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602384 · Cited by 158
Significant correlations between severe fatty liver and risk factors for metabolic syndrome
Hsiao, P., Kuo, K., Shin, S., Yang, Y., Lin, W., Yang, J., Chiu, C., Chuang, W., Tsai, T., & Yu, M. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04698.x · Cited by 155
Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 152
Kirk, E. A., Sagawa, Z. K., McDonald, T. O., O'Brien, K. D., & Heinecke, J. W. (2008) · Diabetes · doi:10.2337/db07-1061 · Cited by 149
Huang, J., Iqbal, J., Saha, P., Liu, J., Chan, L., Hussain, M. M., Moore, D. D., & Wang, L. (2007) · Hepatology · doi:10.1002/hep.21632 · Cited by 146
Understanding bile acid signaling in diabetes: From pathophysiology to therapeutic targets
Ferrell, J. M., & Chiang, J. Y. L. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0043 · Cited by 139
André, P., Balkau, B., Vol, S., Charles, M.-A. A., Eschwège, É., & on behalf of the DESIR Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0440 · Cited by 138
Nagle, C. A., An, J., Shiota, M., Torres, T. P., Cline, G. W., Liu, Z., Wang, S., Catlin, R. L., Shulman, G. I., Newgard, C. B., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611550200 · Cited by 136
García‐Cañaveras, J. C., Donato, M. T., Castell, J. V., & Lahoz, A. (2011) · Journal of Proteome Research · doi:10.1021/pr200629p · Cited by 130
Incretin mimetics as a novel therapeutic option for hepatic steatosis
Tushuizen, M. E., Bunck, M. C. M., Pouwels, P. J. W., van Waesberghe, J. H. T., Diamant, M., & Heine, R. J. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01315.x · Cited by 127
Sex‐differential Expression of Metabolism‐related Genes in Response to a High‐fat Diet
Priego, T., Sánchez, J., Picó, C., & Palou, A. (2008) · Obesity · doi:10.1038/oby.2007.117 · Cited by 123
Grefhorst, A., van Dijk, T. H., Hammer, A., van der Sluijs, F. H., Havinga, R., Havekes, L. M., Romijn, J. A., Groot, P. H. E., Reijngoud, D., & Kuipers, F. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2005 · Cited by 126
Self-citationLee, Y. M., Choi, J. S., Kim, M. H., Jung, M. H., Lee, Y. S., & Song, J. (2006) · Nutrition · doi:10.1016/j.nut.2005.12.014 · Cited by 116
Wu, C., Yang, M., Chan, K., Chung, P.-J., Ou, T., & Wang, C. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101415v · Cited by 115
Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver
Guillén, N., Navarro, M. Á., Arnal, C., Noone, E., Arbonés-Mainar, J. M., Acı́n, S., Surra, J. C., Muniesa, P., Roche, H. M., & Osada, J. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90339.2008 · Cited by 113
de Oliveira, C. P. M. S., Stefano, J. T., de Siqueira, É. R. F., Silva, L. S., Mazo, D. F. D. C., de Lima, V. M. R., Junior, C. K. F., de Mello, E. S., Souza, F., Rabelo, F., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00215.x · Cited by 109
Pathogenesis of NASH: Animal Models
London, R. M., & George, J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.010 · Cited by 108
Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2170-0 · Cited by 104
Toye, A. A., Dumas, M., Blancher, C., Rothwell, A. R., Fearnside, J., Wilder, S. P., Bihoreau, M.-T., Cloarec, O., Azzouzi, I., Young, S., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0738-5 · Cited by 104
Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice.
Longo, K., Charoenthongtrakul, S., Giuliana, D. J., Govek, E., McDonagh, T., Qi, Y., Distefano, P., & Geddes, B. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.03.011 · Cited by 105
Fujimoto, Y., Onoduka, J., Homma, K. J., Yamaguchi, S., Mori, M., Higashi, Y., Makita, M., Kinoshita, T., Noda, J.-I., Itabe, H., et al. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.2174 · Cited by 104
Ins and Outs Modulating Hepatic Triglyceride and Development of Nonalcoholic Fatty Liver Disease
Goldberg, I. J., & Ginsberg, H. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.040 · Cited by 99
D'Souza, N. B., Kovacs, E. J., Witte, P. D., Spies, C., Littleton, J. M., de Villiers, W. J. S., Lott, A. J., Plackett, T. P., Lanzke, N., & Meadows, G. G. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01234.x · Cited by 100
Cong, W.-N., Tao, R., Tian, J., Liu, G.-T., & Ye, F. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.022 · Cited by 97
Ginneken, V., Verhey, E., Poelmann, R. E., Ramakers, R. E. F. S., van Dijk, K. W., Ham, L., Voshol, P. J., Havekes, L. M., Eck, M. V., & van der Greef, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.07.007 · Cited by 97
Self-citationPamir, N., McMillen, T. S., Kaiyala, K. J., Schwartz, M. W., & LeBoeuf, R. C. (2009) · Endocrinology · doi:10.1210/en.2009-0137 · Cited by 91
Deevska, G. M., Rozenova, K. A., Giltiay, N. V., Chambers, M. A., White, J., Boyanovsky, B. B., Jia, W. P., Daugherty, A., Smart, E. J., Reid, M. B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807800200 · Cited by 91
Raju, J., & Bird, R. P. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803254 · Cited by 93
Taveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D. G., Arthus, M.-F., Magnan, C., Philippe, E., Paradis, V., Foufelle, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3496-9 · Cited by 86
Mammalian phospholipase D: Function, and therapeutics
McDermott, M. I., Wang, Y., Wakelam, M. J. O., & Bankaitis, V. A. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101018 · Cited by 89
den Boer, M. A. M., Voshol, P. J., der Elst, J. P. S.-V., Korsheninnikova, E., Ouwens, D. M., Kuipers, F., Havekes, L. M., & Romijn, J. A. (2006) · Endocrinology · doi:10.1210/en.2006-0417 · Cited by 85
Self-citationWoodie, L. N., Luo, Y., Wayne, M. J., Graff, E. C., Ahmed, B., O’Neill, A. M., & Greene, M. W. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.004 · Cited by 78
Investigation of the Anti-Obesity Action of Licorice Flavonoid Oil in Diet-Induced Obese Rats
Kamisoyama, H., Honda, K., TOMINAGA, Y., Yokota, S., & HASEGAWA, S. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.80469 · Cited by 75
Dynamic Regulation of Hepatic Lipid Droplet Properties by Diet
Crunk, A. E., Monks, J., Murakami, A., Jackman, M. R., MacLean, P. S., Ladinsky, M. S., Bales, E. S., Cain, S., Orlicky, D. J., & McManaman, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067631 · Cited by 74
Tu, P., Bhasin, S., Hruz, P. W., Herbst, K. L., Castellani, L. W., Hua, N., Hamilton, J. A., & Guo, W. (2009) · Diabetes · doi:10.2337/db09-0349 · Cited by 72
Ferritin, metabolic syndrome and NAFLD: Elective attractions and dangerous liaisons
Trombini, P., & Piperno, A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.004 · Cited by 68
de Roos, B., Duivenvoorden, I., Rucklidge, G. J., Reid, M., Ross, K., Lamers, R.-J. A. N., Voshol, P. J., Havekes, L. M., & Teusink, B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2974fje · Cited by 70
Self-citationYuan, X., Liang, X., Liu, L., Fang, J., Li, J., Li, A., Cai, W., Xue, M., Wang, J., & Wang, Q. (2016) · Fish Physiology and Biochemistry · doi:10.1007/s10695-016-0240-4 · Cited by 69
Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice
Fourcot, A., Couchie, D., Chobert, M.-N., Zafrani, E., Mavier, P., Laperche, Y., & Brouillet, A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00311.2010 · Cited by 71
Nunes-Souza, V., César-Gomes, C. J., da Fonseca, L. J. S., Guedes, G. D. S., Smaniotto, S., & Rabelo, L. A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1987960 · Cited by 70
Guillén, N., Acı́n, S., Navarro, M. Á., Perona, J. S., Arbonés-Mainar, J. M., Arnal, C., Sarría, A. J., Surra, J. C., Carnicer, R., Orman, I., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.008 · Cited by 68
Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes
Saberi, M., Bjelica, D., Schenk, S., Imamura, T., Bandyopadhyay, G. K., Li, P., Jadhar, V., Vargeese, C., Wang, W., Bowman, K., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2009 · Cited by 66
Histone variant macroH2A1 deletion in mice causes female-specific steatosis
Boulard, M., Storck, S., Cong, R., Pinto, R. O., Delage, H., & Bouvet, P. (2010) · Epigenetics & Chromatin · doi:10.1186/1756-8935-3-8 · Cited by 67
Grefhorst, A., Hoekstra, J., Derks, T. G. J., Ouwens, D. M., Baller, J. F. W., Havinga, R., Havekes, L. M., Romijn, J. A., & Kuipers, F. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2005 · Cited by 68
Self-citationArbonés-Mainar, J. M., Ross, K., Rucklidge, G. J., Reid, M., Duncan, G., Arthur, J. R., Horgan, G. W., Navarro, M. Á., Carnicer, R., Arnal, C., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070321a · Cited by 66
Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview
Varga, O., Harangi, M., Olsson, I. A. S., & Hansen, A. K. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00667.x · Cited by 68
Maternal High-Fat Diet Programs for Metabolic Disturbances in Offspring despite Leptin Sensitivity
Volpato, A. M., Schultz, A., Magalhães-da-Costa, E., Correia, M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2012) · Neuroendocrinology · doi:10.1159/000336377 · Cited by 71
Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles
Vesterdal, L. K., Danielsen, P. H., Folkmann, J. K., Jespersen, L. F., Aguilar-Pelaez, K., Roursgaard, M., Loft, S. H., & Möller, P. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.001 · Cited by 63
Rosa, D. D., Grześkowiak, Ł. M., Ferreira, C. L. L. F., Fonseca, A. C. M., Reis, S. A., Dias, M. M., Siqueira, N. P., Silva, L. L., Neves, C. A., Oliveira, L. L., et al. (2016) · Food & Function · doi:10.1039/c6fo00339g · Cited by 62
Hao, L., Lu, X., Sun, M., Li, K., Shen, L., & Wu, T. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.28886 · Cited by 64
Commonly used animal models of non-alcoholic steatohepatitis.
Fan, J., & Qiao, L. (2009) · PubMed · Cited by 60
Chen, W., Wilson, J. L., Khaksari, M., Cowley, M. A., & Enriori, P. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00078.2012 · Cited by 60
Quintás‐Cardama, A., Portillo, N., García‐Cañaveras, J. C., Castell, J. V., Ferrer, A., & Lahoz, A. (2011) · Metabolomics · doi:10.1007/s11306-011-0292-5 · Cited by 59
Donato, M. T., & Gómez-Lechón, M. J. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850001 · Cited by 59
Gourineni, V., Shay, N. F., Chung, S., Sandhu, A. K., & Gu, L. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf3013663 · Cited by 58
Stacchiotti, A., Favero, G., Lavazza, A., Golić, I., Aleksic, M., Korać, A., Rodella, L. F., & Rezzani, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148115 · Cited by 57
Díaz, M. B., Krones, A., Metzger, D., Ziegler, A., Vegiopoulos, A., Klingenspor, M., Müller‐Decker, K., & Herzig, S. (2008) · Hepatology · doi:10.1002/hep.22383 · Cited by 60
Han, J., Lee, J., Kim, H.-G., Seol, I.-C., Im, H.-J., Cho, J.-H., & Son, C. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.07.021 · Cited by 54
Souza‐Mello, V., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507771878 · Cited by 54
Atherogenic diet-induced hepatitis is partially dependent on murine TLR4
Desai, M. S., Mariscalco, M. M., Tawil, A., Vallejo, J. G., & Smith, C. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607390 · Cited by 54
Li, T., Zhu, R., Dong, Y., Liu, Y., Li, S., & Chen, G. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf400283w · Cited by 53
Effect of garlic on high fat induced obesity
Kim, M., & Kim, H. (2011) · Acta Biologica Hungarica · doi:10.1556/abiol.62.2011.3.4 · Cited by 50
López‐Parra, M., Titos, E., Horrillo, R., Ferré, N., González‐Périz, A., Martínez‐Clemente, M., Planagumà, A., Masferrer, J. L., Arroyo, V., & Clària, J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800101-jlr200 · Cited by 50
Sánchez‐Salgado, J. C., Ortíz‐Andrade, R., Aguirre-Crespo, F. J., Vergara-Galicia, J., León‐Rivera, I., Montes, S., Villalobos‐Molina, R., & Estrada-Soto, S. E. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.08.008 · Cited by 49
Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
Abruzzese, G. A., Heber, M. F., Ferreira, S. R., Vélez, L. M., Reynoso, R., Pignataro, O. P., & Motta, A. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0471 · Cited by 48
Correia, M. L., Volpato, A. M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.61 · Cited by 51
Perilla leaf extract ameliorates obesity and dyslipidemia induced by high‐fat diet
Kim, M., & Kim, H. K. (2009) · Phytotherapy Research · doi:10.1002/ptr.2811 · Cited by 46
Allick, G., Bisschop, P. H. L. T., Ackermans, M. T., Endert, E., Meijer, A. J., Kuipers, F., Sauerwein, H. P., & Romijn, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1041 · Cited by 46
Self-citationThe blind men 'see' the elephant-the many faces of fatty liver disease
Girija, S. M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.831 · Cited by 45
Metadata
- Authors
- den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., & Romijn, J. A.
- Affiliations
- From TNO Prevention and Health (M.d.B., P.J.V., L.M.H.), Gaubius Laboratory Leiden, Leiden, The Netherlands; Department of Endocrinology and Diabetes (M.d.B., P.J.V., J.A.R.), Department of General Internal Medicine (L.M.H.), and Department of Cardiology (L.M.H.), Leiden University Medical Center, Leiden, The Netherlands; and Center for Liver, Digestive, and Metabolic Diseases (F.K.), Department of Pediatrics, University Hospital Groningen, Groningen, The Netherlands.
- Leiden University (NL)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2004-04
- Volume
- 24
- Issue
- 4
- Pages
- 644-649
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2160518844
- Cited by
- 260
- References
- 49
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 13 · 2016: 15 · 2015: 17 · 2014: 5 · 2013: 6 · 2012: 16
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- TNO Repository (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hepatic steatosis, metabolic syndrome, non-alcoholic fatty liver disease, triglyceride accumulation, hepatic insulin resistance, visceral obesity, dyslipidemia, type 2 diabetes, rodent models
- MeSH terms
- Adipose Tissue, Animals, Diabetes Mellitus, Type 2, Dogs, Fatty Acids, Fatty Liver, Glucose, Homeostasis, Humans, Hyperlipidemias, Insulin Resistance, Liver, Models, Biological, Obesity, Rats, Zucker, Transcription, Genetic, Triglycerides, Models, Animal, Metabolic Syndrome, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review